期刊名称：CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Canadian Urological Association Journal (CUAJ) is a peer-reviewed journal,specializing in original scientific publications and selected review
articles from Canadian and international authors.
CUAJ also publishes case reports, resident studies and opinion pieces.
Instructions to Authors
Dr. Laurence Klotz, editor-in-chief, is pleased to receive submissions from urologists and other physicians involved in studies of urologic diseases. All material submitted for publication must be sent exclusively to CUAJ.
Manuscripts should adhere to the standards set by the International Committee of Medical Journal Editors (www.icmje.org). If you have any questions about your submission, please contact the Editorial Director, Josephine Sciortino, at josephine.sciortino@cua.org.
Your submission should include:
- Title
- Names, addresses, email addresses, and positions of all authors; indicate the name of the corresponding author
- Copyright statement to the effect of: The corresponding author has the right to grant on behalf of all authors, and does grant on behalf of all authors, an exclusive license (or non exclusive for government employees) on a worldwide basis to the Canadian Urological Association Journal to permit this article (if accepted) to be published in the CUAJ.
- Competing interest statement: A conflict of interest exists when an author or the author's institution has financial or personal relationships with other people or organizations that inappropriately influence (bias) his or her actions. Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships, academic competition, or intellectual passion. A conflict can be actual or potential, and full disclosure to the editor-in-chief is the safest course. All submissions to CUAJ must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest.
- Abstract: A clearly written abstract is crucial for the purpose of peer and editorial review of the manuscript. The abstract should contain the following sections: background (the rationale for the study), methods (how the study was done), results (the principal findings), Interpretation (a discussion of the results). Maximum word length is 250.
- Main manuscript: The main text should not be longer than 2000 words, not including references, tables and figures. Special dispensation for longer articles may be requested from the editor.
- For tables, figures and graphics: Please indicate the file format and compression type in an email message or on the disk label. The original file should be sent in the native format in which the application was created. A hard copy proof of all digital art MUST be submitted for verification purposes (fax: 514-875-0205). If the electronic file is unusable for any reason or no electronic file exists, you will be asked to supply camera-ready art or data. We will acknowledge receipt of your digital art submission within a few days. If you do not hear from us, please confirm that the file has been received.
File formats accepted
- Microsoft Word, Excel, PowerPoint (Mac 98, PC 97, XP, Windows 2003), Word Perfect (Mac 3.5, PC 9)
- QuarkXpress (Mac 4.1)
- Adobe Illustrator (Mac 9)
- Adobe Photoshop (Mac/PC 5.5)
Image formats accepted
- GIF 300 dpi
- JPEG 300 dpi, minimum compression (photos only, no text, 300 dpi)
- TIFF (photos only, no text, 300 dpi)
- Images must be line art, grayscale or CMYK (no RGB)
- Illustrator EPS MAC CS3
Email your submission, as an attachment, to:Josephine Sciortino, Managing Editor
Email: journal@cua.org
Mail your submission, as a CD-ROM, to:Josephine Sciortino, Managing Editor
CUAJ-JAUC
1155 University, Suite 1303
Montreal QC H3B 3A7
For all inquires, contact the managing editor at: josephine.sciortino@cua.org.
Editorial Board
FOUNDING EDITOR/EDITOR-IN-CHIEF
Laurence Klotz, MD, FRCSC
Professor, Department of Surgery, University of Toronto, Chief of Urology, Sunnybrook Health Sciences Centre and Women�College Hospital, Chairman of the Canadian Urologic Oncology Group, Toronto, ON
Bladder CancerYves Fradet, MD, FRCSC
Professor of Surgery/Urology, Laval University, Director, Department of Surgery, Staff Urologist, CHUQ-HéŒel-Dieu de Qué–Žec, Qué–Žec, QC
Clinical EpidemiologyPierre Karakiewicz, MD, FRCSC
Urologic Oncologist, Assistant Professor and Outcomes Research Scientist, Director, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montré–l, QC
Community UrologyDr. R. Ian Reid, MD, FRCSC
Urologist, Queen Elizabeth Hospital, Charlottetown, PEI
EndourologyJohn D. Denstedt, MD, FRCSC
Professor and Chair of Surgery, Division of Urology, University of Western Ontario, St. Joseph�Health Care London, London, ON
Erectile DysfunctionGerald B. Brock, MD, FRCSC
Professor of Surgery, Division of Urology, University of Western Ontario, London, ON
IncontinenceJerzy B. Gajewski, MD, FRCSC
Professor of Urology & Pharmacology, Director of Functional Urology, Department of Urology, Dalhousie University, Halifax, NS
Infectious Disease and ProstatitisJ. Curtis Nickel, MD, FRCSC
Professor, Department of Urology, Queen�University, Staff Urologist, Kingston General Hospital, Kingston, ON
InfertilityKeith A. Jarvi, MD, FRCSC
Professor, Department of Surgery, Division of Urology, University of Toronto, Director, Murray Koffler Urologic Wellness Centre, Mount Sinai Hospital, Toronto, ON
Kidney CancerMichael Jewett, D, FRCSC, FACS
Division of Urology and Department of Surgical Oncology, Princess Margaret Hospital, University Health
Network, Professor, Department of Surgery (Urology), University of Toronto, Toronto, ON
Minimally Invasive Surgery/Image Guided TherapyPatrick Luke, MD, FRCSC
Assistant Professor of Surgery, University of Western Ontario, London Health Sciences Centre, University Hospital, London, ON
Neurourology/ReconstructionSender Herschorn, BSC, MDCM, FRCSC
Professor and Chair Division of Urology, University of Toronto, Attending Staff, Sunnybrook Health Sciences Centre and Women�College Hospital, Toronto, ON
Pediatric UrologyAndrew E. MacNeily, MD, FRCSC, FAAP
Associate Professor of Urology, Department of Urological Sciences, Head, Division of Pediatric Urology, UBC, BC Children�and Women�Hospital, Vancouver, BC
Prostate CancerArmen Aprikian, MD, FRCSC
Professor and Head, Division of Urology, McGill University, Urologist-in-Chief, McGill University Health Centre Director, Department of Oncology, McGill University Health Centre, Montré–l, QC
Testis and Penile CancerRobert Siemens, MD, FRCSC
Associate Professor, Department of Urology, Queen�University, Kingston, ON
CONSULTING EDITORS
Serge Carrier, MD, FRCSC
Urologist and Assistant Professor of Surgery and Urology Program Director, Division of Urology, McGill University, Montré–l, QC
Richard W. Casey, HBSc, MD, FRCSC
Chief, Department of Urology, Surgeon, Halton Healthcare, Director, The Male Health Centres, Oakville, ON
Michael Chetner, MD, FRCSC
Director, Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB
Joseph L. Chin, MD, FRCSC
Chair, Division of Surgical Oncology, Professor of Urology and Oncology, University of Western Ontario, London, ON
Jacques A. Corcos, MD, FRCSC
Professor of Surgery/Urology, McGill University, Chief of the Department of Urology, Sir Mortimer B. Davis Jewish General Hospital, Director of the Urology Unit, Shriners?Hospital, Director of Urology Unit, Rehabilitation Institute of Montré–l, Montré–l, QC
Mostafa M. Elhilali, MD, PhD, FRCSC
Department of Surgery, McGill University, Montré–l, QC
Neil Fleshner, MD, MPH, FRCSC
Head of Division of Urology, Princess Margaret Hospital, University Health Network, Toronto, ON
Ronald Gerridzen, MD, FRCSC, FACS
Professor, Department of Surgery, Chair, Division of Urology, University of Ottawa, Chief, Division of Urology, The Ottawa Hospital, Urologist, The Ottawa Hospital, Ottawa, ON
Martin E. Gleave, MD, FRCSC, FACS
British Columbia Leadership Chair, Distinguished Professor, Department of Urological Sciences, UBC, Director, The Prostate Centre at VGH, Head, GU Tumour Group, BCCA, Vancouver, BC
Larry Goldenberg, MD, FRCSC, FACS
Professor and Head, Department of Urologic Sciences, UBC, Vancouver, BC
Mireille Gré–“oire, MD, FRCSC
Associate Professor of Surgery/Urology, Laval University, Department of Surgery, Staff Urologist, CHUQ-HéŒel-Dieu de Qué–Žec, Qué–Žec, QC
Anil Kapoor, MD, DABU, FRCSC
Associate Professor of Surgery (Urology), Surgical Director, Renal Transplantation, Urology Director, Centre for Minimal Access Surgery (CMAS), McMaster University, Hamilton, ON
Louis Lacombe, MD, FRCSC
Urologist-Oncologist, Department of Surgery, Staff Urologist, CHUQ-HéŒel-Dieu de Qué–Žec, Qué–Žec, QC
Michael P. Leonard, MD, FRCSC, FAAP
Professor (Surgery and Pediatrics), University of Ottawa, Chief of Pediatric Urology, Children's Hospital of Eastern Ontario, Ottawa, ON
Ronald B. Moore, MD, PhD, FRCSC, FACS
Division of Surgical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB
Richard W. Norman, MD, FRCSC
Professor and Head, Department of Urology, Dalhousie University, District Department Chief, Department of Urology, Capital Health District, Halifax, NS
Kenneth Pace, MD, MSC, FRCSC
Assistant Professor, Division of Urology, Department of Surgery, Co-Director, Fellowship in Endourology and Laparoscopy, St. Michael�Hospital, University of Toronto, Toronto, ON
Hassan A. Razvi, MD, FRCSC
Associate Professor and Chairman, Division of Urology, University of Western Ontario, London, ON
Fred Saad, MD FRCS
Professor of Surgery/Urology, Universit?de Montré–l, Chair in Prostate Cancer, Universit?de Montré–l, Director, Urologic Oncology, Centre Hospitalier de l扷niversit?de Montré–l (CHUM), Montré–l, QC
M. Lynn Stothers, MD, MHSc, FRCSC
Associate Professor of Urology, Director of Research, UBC Bladder Care Centre, Associate Member, Department of Health Care and Epidemiology and Associate Member, Department of Pharmacology, UBC, Vancouver, BC
John Trachetenberg, MD, FRCSC, FACS
Fleck Tanenbaum Chair of Prostatic Disease, Director, Prostate Centre, Princess Margaret Hospital, Professor of Surgery, Professor of Medical Imaging, University of Toronto, Toronto, ON
Luc Valiquette, MD, FRCSC, FACS
Professor of Surgery/Urology, Department of Surgery, Universit?de Montré–l, Urologist, Centre Hospitalier de l扷niversit?de Montré–l (CHUM), Montré–l, QC
James W.L. Wilson, MD, FRCSC
Head, Department of Urology, Queen's University, Kingston General Hospital, Kingston, ON
Tim A. Wollin, MD, FRCSC, MSc
Division of Urology, University of Alberta, Edmonton, AB
|
